These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6484899)

  • 1. Quantitation of factor XIII by SDS polyacrylamide gel electrophoresis.
    Godal HC; Gravem K; Brosstad F; Nyvold N
    Thromb Res; 1984 Sep; 35(5):577-82. PubMed ID: 6484899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin cross-linking in congenital factor XIII deficiency.
    Rodeghiero F; Barbui T
    J Clin Pathol; 1980 May; 33(5):434-7. PubMed ID: 7400341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.
    Fukue H; Anderson K; McPhedran P; Clyne L; McDonagh J
    Blood; 1992 Jan; 79(1):65-74. PubMed ID: 1370210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescent spot test for coagulation factor XIII.
    Coggan M; Board PG
    Anal Biochem; 1984 Mar; 137(2):402-4. PubMed ID: 6731823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin cross-linking.
    Fear JD; Miloszewski KJ; Losowsky MS
    Acta Haematol; 1984; 71(5):304-9. PubMed ID: 6429995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific, fluorescent activity staining procedure applied to plasma and red blood cells in congenital factor XIII deficiency.
    Henriksson P; Stenberg P; Nilsson IM; Rasovic N; Kezic J; Stenbjerg S
    Br J Haematol; 1980 Jan; 44(1):141-7. PubMed ID: 6155132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reversed activity staining procedure for detection of an acquired antibody against factor XIII in a girl with factor XIII deficiency.
    Seiving B; Henriksson P; Stenberg P; Nilsson IM
    Br J Haematol; 1992 Oct; 82(2):414-6. PubMed ID: 1419823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood coagulation factor XIII and fibrin stabilization (author's transl)].
    Rasche H
    Klin Wochenschr; 1975 Dec; 53(24):1137-45. PubMed ID: 765611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and classification of factor XIII deficiencies.
    Kohler HP; Ichinose A; Seitz R; Ariens RA; Muszbek L;
    J Thromb Haemost; 2011 Jul; 9(7):1404-6. PubMed ID: 22946956
    [No Abstract]   [Full Text] [Related]  

  • 10. Epsilon-(gamma-glutamyl) lysine cross-links: determination in fibrin from normal and factor XIII-deficient individuals.
    Pisano JJ; Bronzert TJ; Peyton MP; Finlayson JS
    Ann N Y Acad Sci; 1972 Dec; 202():98-113. PubMed ID: 4629559
    [No Abstract]   [Full Text] [Related]  

  • 11. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of factor XIII activity in plasma.
    Katona É; Pénzes K; Molnár É; Muszbek L
    Clin Chem Lab Med; 2012 Feb; 50(7):1191-202. PubMed ID: 22850052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic factor XIII deficiency with normal urea solubility test.
    Sanfelippo MJ; Mazza JJ; Mercier RJ
    Clin Lab; 2014; 60(12):2099-102. PubMed ID: 25651747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clot retraction in a factor XIII free system.
    Rao KM; Newcomb TF
    Scand J Haematol; 1980 Feb; 24(2):142-8. PubMed ID: 7375813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
    Hellstern P; Schilz K; von Blohn G; Wenzel E
    Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the assay of the plasma factor XIII activity with dansylcadaverine incorporation method (author's transl)].
    Takahashi H; Sakuragawa N; Shibata A
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):516-24. PubMed ID: 495010
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of Factor XIII.
    Muszbek L; Katona É; Kerényi A
    Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII.
    Ragaz S; Kemp G; Furlan M; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):537-41. PubMed ID: 1037151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The subunit composition of factor XIII proteins in normal and factor XIII deficient plasma and serum analysed by line immunoelectrophoresis.
    Krøll J
    Clin Chim Acta; 1989 Feb; 179(3):279-84. PubMed ID: 2714001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen.
    Shen L; Lorand L
    J Clin Invest; 1983 May; 71(5):1336-41. PubMed ID: 6853717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.